Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0022 Transporter Info | ||||
Gene Name | SLC15A2 | ||||
Transporter Name | Peptide transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Cephapirin Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 30699 | ||||
Docking Score | -8.091 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C17H17N3O6S2 | ||||
Molecular Weight | 423.5 | ||||
Canonical SMILES |
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O
|
||||
InChI |
InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1
|
||||
InChIKey | UQLLWWBDSUHNEB-CZUORRHYSA-N | ||||
Pharmaceutical Properties | Xlogp | -1.1 | Rotatable Bond Count | 8 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 9 | ||
Xenobiotic Name | Cyclacillin Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 19003 | ||||
Docking Score | -7.722 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C15H23N3O4S | ||||
Molecular Weight | 341.4 | ||||
Canonical SMILES |
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C
|
||||
InChI |
InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1
|
||||
InChIKey | HGBLNBBNRORJKI-WCABBAIRSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.3 | Rotatable Bond Count | 3 | |
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Xenobiotic Name | Cephalothin Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 6024 | ||||
Docking Score | -7.566 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C16H16N2O6S2 | ||||
Molecular Weight | 396.4 | ||||
Canonical SMILES |
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O
|
||||
InChI |
InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1
|
||||
InChIKey | XIURVHNZVLADCM-IUODEOHRSA-N | ||||
Pharmaceutical Properties | Xlogp | -0.4 | Rotatable Bond Count | 7 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 8 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.